Results 91 to 100 of about 2,191 (125)

Outcomes of Patients with RET Fusion-Positive Non-Small Cell Lung Cancer Treated with First-Line Non-Molecularly Targeted Therapies: A Real-World Benchmark in Europe from the RECALIB-RET Study. [PDF]

Adv Ther
León-Mateos L, Hochmair MJ, Sánchez-Gastaldo A, Rabeau A, Auliac JB, Morán T, Rieke DT, Iranzo Gomez P, Puri T, Afonso AS, Khanal M, Li XI, Segall G.   +12 more
europepmc   +1 more source

Real-world external control arm for the single-arm LIBRETTO-001 trial of selpercatinib in RET-mutation-positive medullary thyroid cancer: RECALIB-RET. [PDF]

ESMO Open
Hadoux J, Hernando J, Wong KH, Do Cao C, Lasolle H, Buffet C, Benisvy D, Illouz F, Schneegans O, Varnier R, Drui D, Zanetta S, Hescot S, Muller M, Nascimento C, Roudaut N, Khanal M, Zheng S, Li X, Singh R, Tian W, Afonso AS, Houot B, Borget I, Segall G.   +24 more
europepmc   +1 more source

Pan-tumor validation of FoundationOne^®CDx as a companion diagnostic for <i>RET</i> fusions as a predictor of response to selpercatinib. [PDF]

Front Oncol
van den Hout A, Huang RSP, Ho C, Smith DL, Mata DA, Kaur B, Wijayawardana SR, Wright J, Szpurka AM, Lin DI.   +9 more
europepmc   +1 more source

Highlights of ASCO 2026. [PDF]

Oncologist
DaSilva BA, Neugut AI, Fojo T, Bates SE.
europepmc   +1 more source

Clinical Activity of RET TKI Plus Chemotherapy After Progression on a RET TKI in a <i>RET</i> Fusion-Positive NSCLC Real-World Cohort: A Brief Report. [PDF]

JTO Clin Res Rep
Paula AG, Liu X, Karimi A, Concannon K, Heeke S, Elamin YY, Wang K, Pozadzides JV, Vokes N, Tu J, Tsao A, Negrao MV, Zhang J, Singhi EK, Zhang B, Rinsurongkawong W, Martins IG, Tran HT, Gibbons DL, Nilsson MB, Heymach JV.   +20 more
europepmc   +1 more source

<i>RET</i>-Targeted Neoadjuvant Therapy Enables Curative Surgery in an Ultra-Elderly Patient With Recurrent Colon Cancer Harboring a CCDC6-RET Fusion. [PDF]

JCO Precis Oncol
Jin T, Cricri M, Chen X, He J, Liu Y.
europepmc   +1 more source

Unique hypersensitivity syndrome secondary to selpercatinib

JAAD Case Reports
Siddharth Srikakolapu, MD, Dev R. Sahni, MD, Lauren M. Madigan, MD   +2 more
doaj   +1 more source

<i>RET</i> fusion partners dictate oncogenic potential in undifferentiated spindle cell sarcomas. [PDF]

Cancer Biol Ther
Gui Q, Zhang Y, Yang M, Liang R, Huang M, Yang X, Chen N, Chen X, Wu M, Chen H, Meng L, Xiao S, Tao M.   +12 more
europepmc   +1 more source

Targeting Oncogenic Gene Fusions in Lung Cancer. [PDF]

Cancer J
Nie Y, Wilson FH.
europepmc   +1 more source